Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDS Pharm CoXKRX:464280 40 PB Ratio is 0.65 as of Sep. 13, 2026, which is 52% below its 10-year median of 1.35. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 926 Drug Manufacturers companies, TDS Pharm Co ranks better than 87.47% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-13), TDS Pharm Co's share price is ₩5520.00. TDS Pharm Co's Book Value per Share for the quarter that ended in Jun. 2026 was ₩8,487.46. Hence, TDS Pharm Co's PB Ratio of today is 0.65.
The historical rank and industry rank for TDS Pharm Co's PB Ratio or its related term are showing as below:
XKRX:464280'
s PB Ratio Range Over the Past 10 Years
Min: 0.54 Med: 1.35 Max: 2.71
Current: 0.65
During the past 6 years, TDS Pharm Co's highest PB Ratio was 2.71. The lowest was 0.54. And the median was 1.35.
XKRX:464280's PB Ratio is ranked better than 87.47% of 926
companies
in the Drug Manufacturers industry
Industry Median: 1.95
vs XKRX:464280: 0.65
During the past 12 months, TDS Pharm Co's average Book Value Per Share Growth Rate was 13.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 32.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 24.40% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of TDS Pharm Co was 33.60% per year. The lowest was 12.00% per year. And the median was 32.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
TDS Pharm Co PB Ratio Related Terms
TDS Pharm Co PB Ratio Historical Data
* Premium members only.
The historical data trend for TDS Pharm Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:464280 vs LLY, JNJ, ABBV: PB Ratio Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
TDS Pharm Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
TDS Pharm Co (XKRX:464280) has a PB Ratio of 0.65 as of Sep. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TDS Pharm Co and its competitors. This is 52% below median its historical median of 1.35. Over the past decade, TDS Pharm Co's PB Ratio has ranged from 0.54 to 2.71. According to the industry distribution chart, TDS Pharm Co ranks #116 out of 926 companies in the Drug Manufacturers industry, placing it in the top 12.5%.
Is TDS Pharm Co's PB Ratio too high?
TDS Pharm Co's current PB Ratio of 0.65 is 52% below median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 2.71. The Drug Manufacturers industry median PB Ratio is 1.95. TDS Pharm Co's value of 0.65 is 66.7% below this industry median. Based on the distribution chart, TDS Pharm Co ranks #116 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TDS Pharm Co ranks #116 out of 926 companies for PB Ratio. This places TDS Pharm Co in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.95. TDS Pharm Co's value of 0.65 is 66.7% below this benchmark. Historically, TDS Pharm Co's own PB Ratio has ranged from 0.54 to 2.71 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 1.95, TDS Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.95, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TDS Pharm Co's current PB Ratio of 0.65 is 66.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TDS Pharm Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TDS Pharm Co's current PB Ratio is 0.65, which is 52% below median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current PB Ratio of 0.65. The current PB Ratio is 0.65, which is 52% below median its 10-year median of 1.35 and 66.7% below the Drug Manufacturers industry median of 1.95. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current PB Ratio is 0.65 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
